David Schnell, Director at Trubion Pharmaceuticals, Inc (TRBN), bought 1,830,293 shares at $13.00 ($457K) on 2006-10-17, disclosed to the SEC on 2006-10-19.
Open-market purchase of $457k TRBN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,795,112 | $0 | 0.0% |
| 2 | $13.00 | 528 | $7K | 1.5% |
| 3 | $13.00 | 34,653 | $450K | 98.5% |
| Total | $0.25 avg | 1,830,293 | $457K | 100% |